National Health Investors (NHI) to Release Quarterly Earnings on Monday

National Health Investors (NYSE:NHI) will likely be announcing its Q1 2025 earnings results after the market closes on Monday, May 5th. Analysts expect National Health Investors to post earnings of $1.13 per share and revenue of $85.13 million for the quarter. National Health Investors has set its FY 2025 guidance at 4.590-4.660 EPS.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Tuesday, February 25th. The real estate investment trust reported $1.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.10 by $0.03. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The firm had revenue of $85.75 million for the quarter, compared to analysts’ expectations of $81.13 million. On average, analysts expect National Health Investors to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

National Health Investors Stock Down 0.3 %

NHI stock opened at $75.11 on Monday. The firm has a fifty day moving average price of $73.15 and a two-hundred day moving average price of $72.79. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29. National Health Investors has a 1-year low of $62.61 and a 1-year high of $86.13. The firm has a market cap of $3.51 billion, a price-to-earnings ratio of 25.81, a PEG ratio of 4.42 and a beta of 0.79.

National Health Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 2nd. Investors of record on Monday, March 31st will be given a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.79%. The ex-dividend date is Monday, March 31st. National Health Investors’s dividend payout ratio is presently 115.38%.

Analyst Ratings Changes

A number of equities analysts have commented on NHI shares. Wedbush restated an “outperform” rating and issued a $88.00 target price on shares of National Health Investors in a research note on Monday, March 17th. Truist Financial boosted their price objective on National Health Investors from $70.00 to $76.00 and gave the company a “hold” rating in a research report on Wednesday, March 19th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $85.50.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.